HIV Viremia
Patterns of HIV viremia and viral suppression before diagnosis of non-AIDS-defining cancers in HIV-infected individuals
7
Contribution of Follicular Dendritic Cells to Persistent HIV Viremia
10
What happens to cardiovascular system behind the undetectable level of HIV viremia?
17
Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia
12
HLA-B*44 Is Associated with a Lower Viral Set Point and Slow CD4 Decline in a Cohort of Chinese Homosexual Men Acutely Infected with HIV-1
7
Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort
9
Cd8+ T Cell Effector Function And Transcriptional Regulation During Hiv Pathogenesis
154
Modulation of Human Immunodeficiency Virus (HIV)-Specific Immune Response by Using Efavirenz, Nelfinavir, and Stavudine in a Rescue Therapy Regimen for HIV-Infected, Drug-Experienced Patients
5
Acute HIV revisited: new opportunities for treatment and prevention
10
Impact of maternal HIV 1 viremia on lymphocyte subsets among HIV exposed uninfected infants: protective mechanism or immunodeficiency
9
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study
9
Role of APOBEC3G/F-Mediated Hypermutation in the Control of Human Immunodeficiency Virus Type 1 in Elite Suppressors
6
Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2−/−γc−/− Mouse
5
Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral Therapy
12
Improved Single Copy Assays for Quantification of Persistent HIV 1 Viremia in Patients on Suppressive Antiretroviral Therapy
8
Impaired Monocyte Maturation in Response to CpG Oligodeoxynucleotide Is Related to Viral RNA Levels in Human Immunodeficiency Virus Disease and Is at Least Partially Mediated by Deficiencies in Alpha/Beta Interferon Responsiveness and Production
11
On Optimal Control Pair Treatment: Clinical Management of Viremia Levels In Pathogenic-Induced HIV-1 Infections
9
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.
8
No Evidence of Human Herpesvirus 8 among Iranian Patients Infected with HIV
6
High viremia and low level of transmitted drug resistance in anti retroviral therapy naïve perinatally infected children and adolescents with HIV 1 subtype C infection
9